Cabio Revenue and Competitors

武汉市,

Location

N/A

Total Funding

Foodtech

Industry

Estimated Revenue & Valuation

  • Cabio's estimated annual revenue is currently $2.5M per year.(i)
  • Cabio's estimated revenue per employee is $119,000

Employee Data

  • Cabio has 21 Employees.(i)
  • Cabio grew their employee count by 31% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M435%N/AN/A
#2
$3.5M290%N/AN/A
#3
$0.5M60%N/AN/A
#4
$1.1M110%N/AN/A
#5
$1M100%N/AN/A
#6
$2.4M205%N/AN/A
#7
$1.5M15-29%N/AN/A
#8
$3.5M29-3%N/AN/A
#9
$31.4M16825%N/AN/A
#10
$31.4M16826%N/AN/A
Add Company

What Is Cabio?

CABIO Biotech (Wuhan) Co., Ltd (Abbreviated as “CABIO”) is a biotechnology company that provides high-quality nutrient products and innovative solutions to the customers in nutrition and health around the globe. CABIO utilizes biosynthetic technology as its core and conducts industrial production through sustainable production mode of microbial synthesis with the integrated technology of Directional industrial strains optimization, Fine control of fermentation and High efficiency separation and purification. CABIO is mainly specialized in development, production and sales of food ingredients including Arachidonic acid (ARA), Algal Docosahexaenoic acid (DHA), natural β-Carotene and Sialic acid (SA), and its products are widely used in Infant formula food, dietary supplements, health food and Formula food for special medical use and etc. CABIO is a high-tech enterprise in China which is one of the earliest companies engaged in the production of high value nutrients by fermentation process such as polyunsaturated fatty acids, and it is one of the leading global suppliers of ARA products. CABIO has established two major production sites which comply with the most advanced international standards and a complete international supply chain and service system. Sales of CABIO's products covers China, the United States, Europe, Australia, New Zealand, South Korea, Southeast Asia and more than 30 countries and regions.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$2.5M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cabio News

2022-04-19 - Algal DHA And ARA Market Size, Scope And Forecast | ADM ...

ADM, DSM, Cabio Bioengineering, Koninklijke, Corbion N.V., Lonza Group, Algisys LLC, Alking Bioengineering and Cargill. This Algal DHA And...

2022-04-19 - Algae DHA Market Size, Outlook And Forecast | DSM, Lonza ...

Algae DHA Market Size, Outlook And Forecast | DSM, Lonza, Cellana, JC Biotech, FEMICO, Runke, Bioco, CABIO, Fuxing, Huison · New Jersey, United...

2022-04-17 - Algal DHA And ARA Market Size And Forecast | ADM, DSM ...

ADM, DSM, Cabio Bioengineering, Koninklijke, Corbion N.V., Lonza Group, Algisys LLC, Alking Bioengineering and Cargill.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.5M71-7%N/A